Simplera™ is FDA-approved as the first and only bioequivalent generic to Claro® (florfenicol, terbinafine, mometasone furoate) Otic Solution.
Bioequivalent to Claro
- Same ingredients, same concentrations, and FDA-approved for the same one-dose administration.
Significantly lower cost
- Provides pricing flexibility to your practice.
- Offers a significantly less expensive single-dose treatment for otitis externa in dogs.1
- Easy one-dose, in-office administration.
Effective for up to 30 days
- No at-home applications required.
- Convenient for veterinarians. Easy on dogs and dog owners.
Simplera™ is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius).
IMPORTANT SAFETY INFORMATION:
CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. WARNINGS: Not for use in humans. Keep this and all drugs out of reach of children. Do not use in cats. In case of accidental skin contact, wash area thoroughly with water. Avoid contact with eyes. Humans with known hypersensitivity to florfenicol, terbinafine hydrochloride or mometasone furoate should not handle this product. PRECAUTIONS: Do not administer orally. Do not use in dogs with known tympanic membrane perforation. Reevaluate the dog if hearing loss or signs of vestibular dysfunction are observed during treatment. Use of topical otic corticosteroids has been associated with adrenocortical suppression and iatrogenic hyperadrenocorticism in dogs (see ANIMAL SAFETY on label). Use with caution in dogs with impaired hepatic function (see ANIMAL SAFETY on label). The safe use of Simplera in dogs used for breeding purposes, during pregnancy, or in lactating bitches has not been evaluated. For full prescribing information, visit www.vetoquinolusa.com/simplera-info.
Simplera is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius).
Simplera should be administered by veterinary personnel. Wear eye protection when administering Simplera. Shake before use. Verify the tympanic membrane is intact prior to administration. Administer one dose (1 dropperette) per affected ear.
Refer to the dosage and administration section of the full prescribing information for application instructions.
Simplera contains 16.6 mg/mL florfenicol, 14.8 mg/mL terbinafine (equivalent to 16.6 mg/mL terbinafine hydrochloride) and 2.2 mg/mL mometasone furoate. Inactive ingredients include purified water, propylene carbonate, propylene glycol, ethyl alcohol, and polyethylene glycol.
1. Elanco Product Price List. Updated June 1, 2022.
© 2022 Vetoquinol USA, Inc. Vetoquinol, the Vetoquinol logo are registered trademarks of Vetoquinol, and SIMPLERA is a pending trademark of Vetoquinol. Claro® is a registered trademark of Elanco or its affiliates.